These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

760 related articles for article (PubMed ID: 12086890)

  • 81. MYCN is a novel oncogenic target in pediatric T-cell acute lymphoblastic leukemia.
    Astolfi A; Vendemini F; Urbini M; Melchionda F; Masetti R; Franzoni M; Libri V; Serravalle S; Togni M; Paone G; Montemurro L; Bressanin D; Chiarini F; Martelli AM; Tonelli R; Pession A
    Oncotarget; 2014 Jan; 5(1):120-30. PubMed ID: 24334727
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Lyl1 interacts with CREB1 and alters expression of CREB1 target genes.
    San-Marina S; Han Y; Suarez Saiz F; Trus MR; Minden MD
    Biochim Biophys Acta; 2008 Mar; 1783(3):503-17. PubMed ID: 18160048
    [TBL] [Abstract][Full Text] [Related]  

  • 83. SIL/TAL1 recombination in adult T-acute lymphoblastic leukemia and T-lymphoblastic lymphoma.
    Kwong YL; Chan D; Liang R
    Cancer Genet Cytogenet; 1995 Dec; 85(2):159-60. PubMed ID: 8548743
    [No Abstract]   [Full Text] [Related]  

  • 84. Clinical significance of TAL1 gene alteration in childhood T-cell acute lymphoblastic leukemia and lymphoma.
    Kikuchi A; Hayashi Y; Kobayashi S; Hanada R; Moriwaki K; Yamamoto K; Fujimoto J; Kaneko Y; Yamamori S
    Leukemia; 1993 Jul; 7(7):933-8. PubMed ID: 8321044
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Combined expression of pTalpha and Notch3 in T cell leukemia identifies the requirement of preTCR for leukemogenesis.
    Bellavia D; Campese AF; Checquolo S; Balestri A; Biondi A; Cazzaniga G; Lendahl U; Fehling HJ; Hayday AC; Frati L; von Boehmer H; Gulino A; Screpanti I
    Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3788-93. PubMed ID: 11891328
    [TBL] [Abstract][Full Text] [Related]  

  • 86. T-cell acute lymphoblastic leukemia and the associated basic helix-loop-helix gene SCL/tal.
    Goldfarb AN; Greenberg JM
    Leuk Lymphoma; 1994 Jan; 12(3-4):157-66. PubMed ID: 8167548
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [Abnormal expression of transcription factors LYL1 and LMO2 and interaction between them in myeloid leukemia].
    Meng YS; Wei R; Ai GW; Meng XQ; Zhang YX
    Zhonghua Yi Xue Za Zhi; 2009 Apr; 89(13):890-3. PubMed ID: 19671288
    [TBL] [Abstract][Full Text] [Related]  

  • 88. OLIG2 (BHLHB1), a bHLH transcription factor, contributes to leukemogenesis in concert with LMO1.
    Lin YW; Deveney R; Barbara M; Iscove NN; Nimer SD; Slape C; Aplan PD
    Cancer Res; 2005 Aug; 65(16):7151-8. PubMed ID: 16103065
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Aberrant activation of the GIMAP enhancer by oncogenic transcription factors in T-cell acute lymphoblastic leukemia.
    Liau WS; Tan SH; Ngoc PCT; Wang CQ; Tergaonkar V; Feng H; Gong Z; Osato M; Look AT; Sanda T
    Leukemia; 2017 Aug; 31(8):1798-1807. PubMed ID: 28028313
    [TBL] [Abstract][Full Text] [Related]  

  • 90. T cell tumorigenesis in Lmo2 transgenic mice is independent of V-D-J recombinase activity.
    Drynan LF; Hamilton TL; Rabbitts TH
    Oncogene; 2001 Jul; 20(32):4412-5. PubMed ID: 11466623
    [TBL] [Abstract][Full Text] [Related]  

  • 91. LIM domain proteins in leukaemia and development.
    Sánchez-García I; Rabbitts TH
    Semin Cancer Biol; 1993 Dec; 4(6):349-58. PubMed ID: 8142620
    [TBL] [Abstract][Full Text] [Related]  

  • 92. PTEN microdeletions in T-cell acute lymphoblastic leukemia are caused by illegitimate RAG-mediated recombination events.
    Mendes RD; Sarmento LM; Canté-Barrett K; Zuurbier L; Buijs-Gladdines JG; Póvoa V; Smits WK; Abecasis M; Yunes JA; Sonneveld E; Horstmann MA; Pieters R; Barata JT; Meijerink JP
    Blood; 2014 Jul; 124(4):567-78. PubMed ID: 24904117
    [TBL] [Abstract][Full Text] [Related]  

  • 93. MEIS proteins as partners of the TLX1/HOX11 oncoprotein.
    Milech N; Gottardo NG; Ford J; D'Souza D; Greene WK; Kees UR; Watt PM
    Leuk Res; 2010 Mar; 34(3):358-63. PubMed ID: 19559479
    [TBL] [Abstract][Full Text] [Related]  

  • 94. SIL-TAL1 deletion in T-cell acute lymphoblastic leukemia.
    Janssen JW; Ludwig WD; Sterry W; Bartram CR
    Leukemia; 1993 Aug; 7(8):1204-10. PubMed ID: 8350619
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Enforced expression of E47 has differential effects on Lmo2-induced T-cell leukemias.
    Goodings C; Tripathi R; Cleveland SM; Elliott N; Guo Y; Shyr Y; Davé UP
    Leuk Res; 2015 Jan; 39(1):100-9. PubMed ID: 25499232
    [TBL] [Abstract][Full Text] [Related]  

  • 96. TLX1/HOX11-mediated disruption of primary thymocyte differentiation prior to the CD4+CD8+ double-positive stage.
    Owens BM; Hawley TS; Spain LM; Kerkel KA; Hawley RG
    Br J Haematol; 2006 Jan; 132(2):216-29. PubMed ID: 16398656
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Cross talk among Notch3, pre-TCR, and Tal1 in T-cell development and leukemogenesis.
    Talora C; Cialfi S; Oliviero C; Palermo R; Pascucci M; Frati L; Vacca A; Gulino A; Screpanti I
    Blood; 2006 Apr; 107(8):3313-20. PubMed ID: 16368887
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Development and characterization of T cell leukemia cell lines established from SCL/LMO1 double transgenic mice.
    Chervinsky DS; Lam DH; Zhao XF; Melman MP; Aplan PD
    Leukemia; 2001 Jan; 15(1):141-7. PubMed ID: 11243382
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Core transcriptional regulatory circuit controlled by the TAL1 complex in human T cell acute lymphoblastic leukemia.
    Sanda T; Lawton LN; Barrasa MI; Fan ZP; Kohlhammer H; Gutierrez A; Ma W; Tatarek J; Ahn Y; Kelliher MA; Jamieson CH; Staudt LM; Young RA; Look AT
    Cancer Cell; 2012 Aug; 22(2):209-21. PubMed ID: 22897851
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Ldb1 is required for Lmo2 oncogene-induced thymocyte self-renewal and T-cell acute lymphoblastic leukemia.
    Li L; Mitra A; Cui K; Zhao B; Choi S; Lee JY; Stamos DB; El-Khoury D; Warzecha C; Pfeifer K; Hardwick J; Zhao K; Venters B; Davé UP; Love PE
    Blood; 2020 Jun; 135(25):2252-2265. PubMed ID: 32181817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.